MetLife Investment Advisors »

Crinetics Pharmaceuticals In shares owned by MetLife Investment Advisors

Quarter-by-quarter ownership of Crinetics Pharmaceuticals In (CRNX) shares owned by MetLife Investment Advisors from 13F filings

Historical chart of MetLife Investment Advisors investment in Crinetics Pharmaceuticals In

Tip: Access up to 7 years of quarterly data

All positions including Crinetics Pharmaceuticals In held by MetLife Investment Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Crinetics Pharmaceuticals In by MetLife Investment Advisors

Quarter filed Position value Share count Share price at filing
2023-12-31 $1.2M 34k 35.58
2023-09-30 $1.0M 34k 29.74
2023-06-30 $505k 28k 18.02
2023-03-31 $450k 28k 16.06
2022-12-31 $513k 28k 18.30
2022-09-30 $535k 27k 19.64
2022-06-30 $474k 25k 18.65
2022-03-31 $558k 25k 21.95
2021-12-31 $465k 16k 28.41
2021-09-30 $245k 12k 21.05
2021-06-30 $220k 12k 18.89
2021-03-31 $178k 12k 15.28
2020-12-31 $180k 13k 14.14
2020-09-30 $200k 13k 15.67
2020-06-30 $223k 13k 17.51
2020-03-31 $86k 5.8k 14.74
2019-12-31 $146k 5.8k 25.02
2019-06-30 $147k 5.9k 25.00